| Norditropin (somatropin) / Novo Nordisk |
| Active, not recruiting | 3 | 200 | Europe, Canada, Japan, US, RoW | Somapacitan, Norditropin® | Novo Nordisk A/S | Growth Hormone Deficiency in Children | 11/21 | 09/25 | | |
2021-005607-13: A research study to compare somapacitan once a week with Norditropin® once a day in children who need help to grow |
|
|
| Ongoing | 3 | 395 | Europe, RoW | somapacitan 5 mg/1.5 mL PDS290, Somapacitan 15 mg/1.5 mL PDS290, Solution for injection in pre-filled pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen | Novo Nordisk A/S, Novo Nordisk A/S | Short stature born small for gestational age Turner syndromeNoonan syndromeIdiopathic short stature, Short stature born small for gestational age Turner syndromeNoonan syndromeIdiopathic short stature, Diseases [C] - Hormonal diseases [C19] | | | | |
2020-002974-28: A research study in Chinese children with a low level of hormone to grow. Treatment is somapacitan once a week compared to Norditropin® once a day. |
|
|
| Not yet recruiting | 3 | 110 | RoW | Sogroya 15 mg/1.5 mL PDS290, Solution for injection, Solution for injection in pre-filled pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen, Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen | Novo Nordisk A/S, Novo Nordisk A/S | Growth hormone deficiency in children, Growth hormone deficiency in children, Diseases [C] - Hormonal diseases [C19] | | | | |
NCT04970654 / 2020-002974-28: A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day. |
|
|
| Completed | 3 | 110 | RoW | somapacitan, Norditropin® | Novo Nordisk A/S, Novo Nordisk A/S | Growth Hormone Deficiency in Children | 11/23 | 12/23 | | |
| Recruiting | 3 | 399 | Europe, Canada, Japan, US, RoW | Somapacitan, Norditropin® | Novo Nordisk A/S, Novo Nordisk A/S | SGA, Turner Syndrome, Noonan Syndrome, ISS | 08/24 | 05/27 | | |
NCT04513171: Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children |
|
|
| Completed | 2/3 | 434 | RoW | Y-shape pegylated somatropin, Norditropin®, Norditropin | Xiamen Amoytop Biotech Co., Ltd., Tongji Hospital | Growth Hormone Deficiency | 06/23 | 07/23 | | |
2020-000874-92: A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children with Idiopathic Growth Hormone Deficiency (GHD) Wieloośrodkowe, 24-miesięczne, Randomizowane, Otwarte, Kontrolowane, Równoramienne Badanie Fazy 2 z Podawanym Codziennie Doustnie LUM-201 Dzieciom Wcześniej Nieleczonym w Okresie Przedpokwitaniowym z Idiopatycznym Niedoborem Hormonu Wzrostu (GHD). |
|
|
| Not yet recruiting | 2 | 80 | Europe | LUM-201, Tablet, Injection, Norditropin | Lumos Pharma, Inc., Lumos Pharma | Growth hormone deficiency, Growth hormone deficiency, Diseases [C] - Hormonal diseases [C19] | | | | |
NCT03878446 / 2018-000232-10: A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day |
|
|
| Active, not recruiting | 2 | 62 | Europe, Japan, US, RoW | Somapacitan, Norditropin® | Novo Nordisk A/S | Short Stature Children Born Small for Gestational Age (SGA) | 05/21 | 12/26 | | |
| Active, not recruiting | 2 | 80 | Europe, US, RoW | LUM-201, rhGH Norditropin® pen (34 µg/kg) | Lumos Pharma | Growth Hormone Deficiency | 10/24 | 10/24 | | |
NCT02616562 / 2015-000531-32: Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency |
|
|
| Recruiting | 2 | 74 | Europe, Japan, US, RoW | somapacitan, NNC0195-0092, Norditropin® FlexPro® pen | Novo Nordisk A/S | Growth Hormone Disorder, Growth Hormone Deficiency in Children | 08/24 | 09/24 | | |
NCT04121780: Growth Hormone Replacement Therapy for Retried Professional Football Players |
|
|
| Recruiting | 2 | 42 | US | Growth Hormone, Norditropin® (somatropin [rDNA origin] injection), Placebo | Center for Neurological Studies, Novo Nordisk A/S | TBI (Traumatic Brain Injury), Concussion, Brain, Sport Injury, Anterior Pituitary Hyposecretion Syndrome, Hypopituitarism, Growth Hormone Deficiency | 03/25 | 09/26 | | |
| Active, not recruiting | N/A | 45 | US | Somatropin injection, Recombinant Growth Hormone, Norditropin | Nemours Children's Clinic, Novo Nordisk A/S | Growth Hormone Deficiency, Idiopathic Short Stature | 05/24 | 07/25 | | |
NCT05308927: French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome |
|
|
| Enrolling by invitation | N/A | 221 | Europe | Norditropin, Somatropin | Novo Nordisk A/S | Noonan Syndrome | 03/28 | 03/28 | | |
NCT03972345: Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA) |
|
|
| Enrolling by invitation | N/A | 750 | Europe | Norditropin® FlexPro® | Novo Nordisk A/S | Growth Hormone Deficiency in Children, Born Small for Gestational Age | 06/29 | 06/31 | | |